Century Therapeutics, Inc. (IPSC) has announced the key appointments of Morgan Conn as Chief Financial Officer, starting October 14, 2024, and Chad Cowan as Chief Scientific Officer, commencing October 1, 2024. Both will join the Executive Committee.
Morgan Conn brings over 20 years of expertise in finance and business development within the biopharmaceutical industry, having most recently served as Chief Business Officer at Pharvaris.
Chad Cowan, renowned for his work in stem cell therapy, has been an executive scientific advisor at Century Therapeutics following the acquisition of Clade Therapeutics in April 2024.
